RECK suppresses interleukin‐17/TRAF3IP2‐mediated MMP‐13 activation and human aortic smooth muscle cell migration and proliferation

TRAF3IP2 mediates TWEAK/TWEAKR-induced pro-fibrotic responses in cultured cardiac fibroblasts and the heart

(2018) Nitin A. Das et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

RECK isoforms have opposing effects on cell migration

(2018) Ha Neul Lee et al.   MOLECULAR BIOLOGY OF THE CELL

Associations between knee structural measures, circulating inflammatory factors and MMP13 in patients with knee osteoarthritis

(2018) G. Ruan et al.   OSTEOARTHRITIS AND CARTILAGE

Stress and stem cells: adult Muse cells tolerate extensive genotoxic stimuli better than mesenchymal stromal cells

(2018) Nicola Alessio et al.   Oncotarget

IL-17 Signaling: The Yin and the Yang

(2017) Nilesh Amatya et al.   TRENDS IN IMMUNOLOGY

TRAF3IP2 mediates atherosclerotic plaque development and vulnerability in ApoE −/− mice

(2016) Siva Sankara Vara Prasad Sakamuri et al.   ATHEROSCLEROSIS

Multiple myeloma–derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease

(2016) Jing Fu et al.   JOURNAL OF CLINICAL INVESTIGATION

MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1

(2016) Kazuhiro Yamamoto et al.   MATRIX BIOLOGY

MicroRNA-320 regulates matrix metalloproteinase-13 expression in chondrogenesis and interleukin-1β-induced chondrocyte responses

(2016) F. Meng et al.   OSTEOARTHRITIS AND CARTILAGE

Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2

(2015) Naveen K. Somanna et al.   CELLULAR SIGNALLING

IL-17A, IL-22, IL-6, and IL-21 Serum Levels in Plaque-Type Psoriasis in Brazilian Patients

(2015) Priscilla Stela Santana de Oliveira et al.   MEDIATORS OF INFLAMMATION

Isolation and characterization of novel RECK tumor suppressor gene splice variants

(2015) Marina Trombetta-Lima et al.   Oncotarget

Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration

(2014) Jalahalli M. Siddesha et al.   CELLULAR SIGNALLING

Current Treatment of In-Stent Restenosis

(2014) Fernando Alfonso et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch

(2014) L A Walsh et al.   ONCOGENE

Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin

(2013) Anthony J. Valente et al.   CELLULAR SIGNALLING

RECK Inhibits Stemness Gene Expression and Tumorigenicity of Gastric Cancer Cells by Suppressing ADAM-Mediated Notch1 Activation

(2013) Kun-Jing Hong et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Acetylsalicylic Acid Inhibits IL-18-Induced Cardiac Fibroblast Migration Through the Induction of RECK

(2013) Jalahalli M. Siddesha et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK

(2013) Jalahalli M. Siddesha et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Crystal structures of interleukin 17A and its complex with IL-17 receptor A

(2013) Shenping Liu et al.   Nature Communications

IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2

(2013) Stéphanie Cochaud et al.   Scientific Reports

RECKing MMP: Relevance of Reversion-inducing Cysteine-rich Protein with Kazal Motifs as a Prognostic Marker and Therapeutic Target for Cancer (A Review)

(2012) Siddavaram Nagini   Anti-Cancer Agents in Medicinal Chemistry

TNF-α-mediated proliferation of vascular smooth muscle cells involves Raf-1-mediated inactivation of Rb and transcription of E2F1-regulated genes

(2012) Rebecca Davis et al.   CELL CYCLE

CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction

(2012) Balachandar Venkatesan et al.   CELLULAR SIGNALLING

cAMP response element-binding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis

(2012) Catherine Bui et al.   FASEB JOURNAL

Matrix Metalloproteinase-13 (MMP-13) Directly and Indirectly Promotes Tumor Angiogenesis

(2012) Yasusei Kudo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy

(2012) Anthony J. Valente et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1

(2011) Anthony J. Valente et al.   CELLULAR SIGNALLING

A Disintegrin and Metalloprotease 17 Mediates Neointimal Hyperplasia in Vasculature

(2011) Akira Takaguri et al.   HYPERTENSION

Restenosis after PCI. Part 2: prevention and therapy

(2011) J. Wouter Jukema et al.   Nature Reviews Cardiology

Restenosis after PCI. Part 1: pathophysiology and risk factors

(2011) J. Wouter Jukema et al.   Nature Reviews Cardiology

Regulation and function of miRNA-21 in health and disease

(2011) Regalla Kumarswamy et al.   RNA Biology

MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes

(2010) Nahid Akhtar et al.   ARTHRITIS AND RHEUMATISM

Pathological Neovascularization Is Reduced by Inactivation of ADAM17 in Endothelial Cells but Not in Pericytes

(2010) Gisela Weskamp et al.   CIRCULATION RESEARCH

Role of Matrix Metalloproteinase-9 Dimers in Cell Migration

(2010) Antoine Dufour et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

In-Stent Restenosis in the Drug-Eluting Stent Era

(2010) George D. Dangas et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling

(2010) S Kitajima et al.   ONCOGENE